State Street
PGEN icon

State Street’s Precigen PGEN Stock Holding History

State Street’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$42.1M Buy
10,890,124
+65,264
+0.6% +$268K ﹤0.01% 1833
2025
Q4 		$45.2M Buy
10,824,860
+6,335,033
+141% +$24.5M ﹤0.01% 1785
2025
Q3 		$14.8M Buy
4,489,827
+1,460,727
+48% +$4.12M ﹤0.01% 2399
2025
Q2 		$4.3M Sell
3,029,100
-9,027
-0.3% -$12.8K ﹤0.01% 3012
2025
Q1 		$4.53M Buy
3,038,127
+64,160
+2% +$101K ﹤0.01% 2922
2024
Q4 		$3.33M Buy
2,973,967
+101,903
+4% +$86.9K ﹤0.01% 3131
2024
Q3 		$2.72M Buy
2,872,064
+29,253
+1% +$36.9K ﹤0.01% 3214
2024
Q2 		$4.49M Buy
2,842,811
+17,361
+0.6% +$25.2K ﹤0.01% 2974
2024
Q1 		$4.1M Buy
2,825,450
+140,917
+5% +$202K ﹤0.01% 3006
2023
Q4 		$3.6M Sell
2,684,533
-81,934
-3% -$96.3K ﹤0.01% 3102
2023
Q3 		$3.93M Buy
2,766,467
+173,984
+7% +$247K ﹤0.01% 3038
2023
Q2 		$2.98M Buy
2,592,483
+374,253
+17% +$442K ﹤0.01% 3232
2023
Q1 		$2.35M Buy
2,218,230
+213,565
+11% +$308K ﹤0.01% 3288
2022
Q4 		$3.05M Buy
2,004,665
+75,327
+4% +$130K ﹤0.01% 3247
2022
Q3 		$4.09M Sell
1,929,338
-52,326
-3% -$110K ﹤0.01% 3154
2022
Q2 		$2.65M Sell
1,981,664
-278,675
-12% -$413K ﹤0.01% 3379
2022
Q1 		$4.77M Sell
2,260,339
-4,755,706
-68% -$11.6M ﹤0.01% 3206
2021
Q4 		$26M Buy
7,016,045
+2,166,238
+45% +$9.32M ﹤0.01% 2273
2021
Q3 		$24.2M Sell
4,849,807
-868,355
-15% -$5M ﹤0.01% 2342
2021
Q2 		$37.3M Sell
5,718,162
-1,156,283
-17% -$8.08M ﹤0.01% 2063
2021
Q1 		$47.4M Buy
6,874,445
+3,782,840
+122% +$32M ﹤0.01% 1783
2020
Q4 		$31.5M Sell
3,091,605
-659,277
-18% -$4.27M ﹤0.01% 1951
2020
Q3 		$13.1M Buy
3,750,882
+2,265,972
+153% +$10.8M ﹤0.01% 2291
2020
Q2 		$7.41M Sell
1,484,910
-2,248,212
-60% -$7.65M ﹤0.01% 2572
2020
Q1 		$12.7M Buy
3,733,122
+44,012
+1% +$190K ﹤0.01% 2119
2019
Q4 		$20.2M Sell
3,689,110
-680,826
-16% -$3.83M ﹤0.01% 2124
2019
Q3 		$25M Sell
4,369,936
-87,013
-2% -$591K ﹤0.01% 1917
2019
Q2 		$34.1M Sell
4,456,949
-1,337,011
-23% -$7.2M ﹤0.01% 1735
2019
Q1 		$30.5M Buy
5,793,960
+1,132,345
+24% +$7.85M ﹤0.01% 1768
2018
Q4 		$30.5M Buy
4,661,615
+690,098
+17% +$7.73M ﹤0.01% 1687
2018
Q3 		$68.4M Sell
3,971,517
-370,135
-9% -$5.5M 0.01% 1327
2018
Q2 		$60.5M Buy
4,341,652
+543,896
+14% +$9.19M 0.01% 1362
2018
Q1 		$58.2M Buy
3,797,756
+483,855
+15% +$6.92M ﹤0.01% 1329
2017
Q4 		$38.2M Buy
3,313,901
+718,786
+28% +$10.7M ﹤0.01% 1610
2017
Q3 		$49.3M Buy
2,595,115
+392,074
+18% +$8.07M ﹤0.01% 1377
2017
Q2 		$53.1M Sell
2,203,041
-504,201
-19% -$11.1M ﹤0.01% 1318
2017
Q1 		$53.7M Buy
2,707,242
+669,227
+33% +$14.9M ﹤0.01% 1292
2016
Q4 		$49.1M Sell
2,038,015
-460,664
-18% -$12.8M ﹤0.01% 1276
2016
Q3 		$69.4M Sell
2,498,679
-25,610
-1% -$677K 0.01% 1060
2016
Q2 		$61.6M Buy
2,524,289
+950,359
+60% +$27M 0.01% 1083
2016
Q1 		$52.9M Sell
1,573,930
-57,572
-4% -$1.81M 0.01% 1145
2015
Q4 		$48.7M Buy
1,631,502
+520,853
+47% +$17.6M 0.01% 1196
2015
Q3 		$35M Buy
1,110,649
+89,661
+9% +$4.37M ﹤0.01% 1369
2015
Q2 		$49.4M Sell
1,020,988
-96,313
-9% -$4.06M 0.01% 1275
2015
Q1 		$48.4M Sell
1,117,301
-135,852
-11% -$4.88M 0.01% 1258
2014
Q4 		$33M Buy
1,253,153
+694,733
+124% +$15.2M ﹤0.01% 1458
2014
Q3 		$9.92M Buy
558,420
+21,723
+4% +$444K ﹤0.01% 2189
2014
Q2 		$12.9M Buy
536,697
+356,526
+198% +$7.23M ﹤0.01% 2083
2014
Q1 		$4.53M Buy
180,171
+4,423
+3% +$122K ﹤0.01% 2624
2013
Q4 		$4M Buy
175,748
+63,058
+56% +$1.27M ﹤0.01% 2704
2013
Q3 		$2.55M Buy
+112,690
New +$2.6M ﹤0.01% 2920

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $2.74B AUM 43.59% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OCM
Occam Crest Management Darien, Connecticut $165M AUM
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

State Street's PGEN Position: Q1 2026 in Review

State Street increased its Precigen (PGEN) stake by 0.6% in Q1 2026, buying an estimated $268K and bringing the position to 10,890,124 shares worth $42.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1833.

State Street first reported a position in PGEN in Q3 2013 and has held it in 51 quarters since. The position peaked at $69.4M in Q3 2016. 205 funds tracked by Wall St. Rank hold PGEN as of Q1 2026.

  • State Street held 10,890,124 shares of Precigen worth $42.1M as of Q1 2026.
  • State Street bought 65,264 Precigen shares in Q1 2026, an estimated $268K.
  • Precigen made up ﹤0.01% of State Street's portfolio in Q1 2026, its #1833 holding.
  • State Street first reported a position in Precigen in Q3 2013 and has held it in 51 quarters since.
  • State Street's Precigen position peaked at $69.4M in Q3 2016.
  • 205 funds tracked by Wall St. Rank held Precigen as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.